Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | urinary bladder cancer | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:26039340 | |
|
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | urinary bladder cancer | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:26039340 | |
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:10359570 | PMID:12477932 | PMID:15146197 | PMID:16895901 | PMID:18636554 | PMID:19322201 | PMID:22223826 | PMID:23640736 | PMID:25633185 | PMID:27183438 | PMID:27789685 | PMID:29694949 |
PMID:30833792 | PMID:31067453 |
ANXA2R (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anxa2r2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANXA2R (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANXA2R (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANXA2R (Chlorocebus sabaeus - green monkey) |
|
.
Variants in ANXA2R
8 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 5p15.33-12(chr5:54839-45649861)x3 | copy number gain | See cases [RCV000051810] | Chr5:54839..45649861 [GRCh38] Chr5:54954..45649963 [GRCh37] Chr5:107954..45685720 [NCBI36] Chr5:5p15.33-12 |
pathogenic |
GRCh38/hg38 5p14.1-q11.1(chr5:26593632-50288555)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051834]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051834]|See cases [RCV000051834] | Chr5:26593632..50288555 [GRCh38] Chr5:26593741..49584389 [GRCh37] Chr5:26629498..49620146 [NCBI36] Chr5:5p14.1-q11.1 |
pathogenic |
GRCh38/hg38 5p13.2-12(chr5:35700480-45260029)x3 | copy number gain | See cases [RCV000051835] | Chr5:35700480..45260029 [GRCh38] Chr5:35700582..45260131 [GRCh37] Chr5:35736339..45295888 [NCBI36] Chr5:5p13.2-12 |
pathogenic |
GRCh38/hg38 5p13.2-q11.1(chr5:36374107-51103841)x3 | copy number gain | See cases [RCV000051836] | Chr5:36374107..51103841 [GRCh38] Chr5:36374209..50399675 [GRCh37] Chr5:36409966..50435432 [NCBI36] Chr5:5p13.2-q11.1 |
pathogenic |
GRCh37/hg19 5p13.3-12(chr5:29081195-45294031)x3 | copy number gain | See cases [RCV001310288] | Chr5:29081195..45294031 [GRCh37] Chr5:5p13.3-12 |
pathogenic |
GRCh38/hg38 5p15.33-11(chr5:49978-46114984)x3 | copy number gain | See cases [RCV000135453] | Chr5:49978..46114984 [GRCh38] Chr5:50093..46115086 [GRCh37] Chr5:103093..46150843 [NCBI36] Chr5:5p15.33-11 |
pathogenic |
GRCh38/hg38 5p12(chr5:42804738-43066986)x1 | copy number loss | See cases [RCV000136834] | Chr5:42804738..43066986 [GRCh38] Chr5:42804840..43067088 [GRCh37] Chr5:42840597..43102845 [NCBI36] Chr5:5p12 |
benign |
GRCh38/hg38 5p13.2-q12.1(chr5:35201559-61903141)x3 | copy number gain | See cases [RCV000137302] | Chr5:35201559..61903141 [GRCh38] Chr5:35201661..61198968 [GRCh37] Chr5:35237418..61234725 [NCBI36] Chr5:5p13.2-q12.1 |
pathogenic |
GRCh38/hg38 5p15.33-q13.3(chr5:22149-74412725)x3 | copy number gain | See cases [RCV000138780] | Chr5:22149..74412725 [GRCh38] Chr5:22149..73708550 [GRCh37] Chr5:75149..73744306 [NCBI36] Chr5:5p15.33-q13.3 |
pathogenic |
GRCh38/hg38 5p12(chr5:42720837-43251761)x3 | copy number gain | See cases [RCV000143351] | Chr5:42720837..43251761 [GRCh38] Chr5:42720939..43251863 [GRCh37] Chr5:42756696..43287620 [NCBI36] Chr5:5p12 |
uncertain significance |
GRCh37/hg19 5p15.2-12(chr5:13461664-46098927)x3 | copy number gain | See cases [RCV000239779] | Chr5:13461664..46098927 [GRCh37] Chr5:5p15.2-12 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789) | copy number gain | See cases [RCV000510723] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p14.2-11(chr5:24281195-46389339)x3 | copy number gain | See cases [RCV000512120] | Chr5:24281195..46389339 [GRCh37] Chr5:5p14.2-11 |
likely pathogenic |
GRCh37/hg19 5p15.1-q35.2(chr5:17628741-176575720)x1 | copy number loss | See cases [RCV000511978] | Chr5:17628741..176575720 [GRCh37] Chr5:5p15.1-q35.2 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:113577-180719789)x3 | copy number gain | See cases [RCV000512039] | Chr5:113577..180719789 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p14.1-12(chr5:27227243-45685844)x3 | copy number gain | not provided [RCV000682542] | Chr5:27227243..45685844 [GRCh37] Chr5:5p14.1-12 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:25328-180693344)x3 | copy number gain | not provided [RCV000744323] | Chr5:25328..180693344 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p13.3-12(chr5:31351588-43480111)x3 | copy number gain | not provided [RCV000744593] | Chr5:31351588..43480111 [GRCh37] Chr5:5p13.3-12 |
pathogenic |
GRCh37/hg19 5p15.33-q35.3(chr5:13648-180905029)x3 | copy number gain | not provided [RCV000744317] | Chr5:13648..180905029 [GRCh37] Chr5:5p15.33-q35.3 |
pathogenic |
GRCh37/hg19 5p12(chr5:42978644-43161568)x3 | copy number gain | not provided [RCV000744676] | Chr5:42978644..43161568 [GRCh37] Chr5:5p12 |
benign |
GRCh37/hg19 5p13.2-11(chr5:34453883-46389339)x3 | copy number gain | not provided [RCV000848003] | Chr5:34453883..46389339 [GRCh37] Chr5:5p13.2-11 |
pathogenic |
Single allele | deletion | Neurodevelopmental disorder [RCV000787436] | Chr5:14685137..149511942 [GRCh37] Chr5:5p15.2-q32 |
uncertain significance |
GRCh37/hg19 5p12(chr5:42802309-43040495)x1 | copy number loss | not provided [RCV000846615] | Chr5:42802309..43040495 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.451C>T (p.Pro151Ser) | single nucleotide variant | Inborn genetic diseases [RCV003292131] | Chr5:43039596 [GRCh38] Chr5:43039698 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.391G>A (p.Asp131Asn) | single nucleotide variant | Inborn genetic diseases [RCV003272224] | Chr5:43039656 [GRCh38] Chr5:43039758 [GRCh37] Chr5:5p12 |
uncertain significance |
GRCh37/hg19 5p13.1-q11.1(chr5:38432180-49441945)x3 | copy number gain | not provided [RCV001005674] | Chr5:38432180..49441945 [GRCh37] Chr5:5p13.1-q11.1 |
pathogenic |
GRCh37/hg19 5p13.2-11(chr5:36053583-46389339)x3 | copy number gain | musculoskeletal system issues [RCV002284293] | Chr5:36053583..46389339 [GRCh37] Chr5:5p13.2-11 |
pathogenic |
GRCh37/hg19 5p13.2-11(chr5:34984696-46405042)x3 | copy number gain | not provided [RCV001537930] | Chr5:34984696..46405042 [GRCh37] Chr5:5p13.2-11 |
pathogenic |
GRCh37/hg19 5p14.1-11(chr5:26382110-46389339) | copy number gain | not specified [RCV002053485] | Chr5:26382110..46389339 [GRCh37] Chr5:5p14.1-11 |
pathogenic |
NC_000005.9:g.(?_42688972)_(44388784_?)del | deletion | not provided [RCV001956361] | Chr5:42688972..44388784 [GRCh37] Chr5:5p12 |
pathogenic |
GRCh37/hg19 5p13.3-11(chr5:29348753-46389339)x3 | copy number gain | not provided [RCV002474514] | Chr5:29348753..46389339 [GRCh37] Chr5:5p13.3-11 |
pathogenic |
NM_001014279.3(ANXA2R):c.449C>T (p.Pro150Leu) | single nucleotide variant | Inborn genetic diseases [RCV002821610] | Chr5:43039598 [GRCh38] Chr5:43039700 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.497T>C (p.Leu166Pro) | single nucleotide variant | Inborn genetic diseases [RCV002986583] | Chr5:43039550 [GRCh38] Chr5:43039652 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.344G>C (p.Arg115Thr) | single nucleotide variant | Inborn genetic diseases [RCV002849864] | Chr5:43039703 [GRCh38] Chr5:43039805 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.413T>G (p.Val138Gly) | single nucleotide variant | Inborn genetic diseases [RCV002984753] | Chr5:43039634 [GRCh38] Chr5:43039736 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.67C>G (p.Gln23Glu) | single nucleotide variant | Inborn genetic diseases [RCV003175833] | Chr5:43039980 [GRCh38] Chr5:43040082 [GRCh37] Chr5:5p12 |
uncertain significance |
NM_001014279.3(ANXA2R):c.34G>A (p.Ala12Thr) | single nucleotide variant | Inborn genetic diseases [RCV003361398] | Chr5:43040013 [GRCh38] Chr5:43040115 [GRCh37] Chr5:5p12 |
uncertain significance |
GRCh38/hg38 5p13.3-12(chr5:29299893-45899898)x3 | copy number gain | See cases [RCV003482191] | Chr5:29299893..45899898 [GRCh38] Chr5:5p13.3-12 |
likely pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RH41910 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | adipose tissue | appendage | entire extraembryonic component | |
High | ||||||||||||||||
Medium | 68 | 154 | 19 | 3 | 544 | 4 | 10 | 6 | 12 | 27 | 52 | 68 | 13 | 3 | ||
Low | 2332 | 2726 | 1568 | 483 | 1395 | 328 | 4061 | 2011 | 2655 | 361 | 1384 | 1529 | 167 | 1191 | 2678 | 4 |
Below cutoff | 34 | 108 | 139 | 136 | 9 | 133 | 214 | 180 | 1060 | 31 | 24 | 15 | 6 | 107 | 1 |
RefSeq Acc Id: | ENST00000314890 ⟹ ENSP00000315915 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000616064 ⟹ ENSP00000479862 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001014279 ⟹ NP_001014301 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001382352 ⟹ NP_001369281 | ||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
Protein RefSeqs | NP_001014301 | (Get FASTA) | NCBI Sequence Viewer |
NP_001369281 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH67873 | (Get FASTA) | NCBI Sequence Viewer |
AAK52335 | (Get FASTA) | NCBI Sequence Viewer | |
EAW56037 | (Get FASTA) | NCBI Sequence Viewer | |
EAW56038 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000315915 | ||
ENSP00000315915.3 | |||
ENSP00000479862 | |||
ENSP00000479862.1 | |||
GenBank Protein | Q3ZCQ2 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_001014301 ⟸ NM_001014279 |
- UniProtKB: | Q8NHX5 (UniProtKB/Swiss-Prot), Q3ZCQ2 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001369281 ⟸ NM_001382352 |
- UniProtKB: | Q3ZCQ2 (UniProtKB/Swiss-Prot), Q8NHX5 (UniProtKB/Swiss-Prot) |
RefSeq Acc Id: | ENSP00000479862 ⟸ ENST00000616064 |
RefSeq Acc Id: | ENSP00000315915 ⟸ ENST00000314890 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q3ZCQ2-F1-model_v2 | AlphaFold | Q3ZCQ2 | 1-193 | view protein structure |
RGD ID: | 6802912 | ||||||||
Promoter ID: | HG_KWN:50059 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | NM_001014279, UC003JNF.1 | ||||||||
Position: |
|
RGD ID: | 6802911 | ||||||||
Promoter ID: | HG_KWN:50062 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell_2Hour, HeLa_S3, Lymphoblastoid | ||||||||
Transcripts: | ENST00000314890 | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:33463 | AgrOrtholog |
COSMIC | ANXA2R | COSMIC |
Ensembl Genes | ENSG00000177721 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Transcript | ENST00000314890 | ENTREZGENE |
ENST00000314890.3 | UniProtKB/Swiss-Prot | |
ENST00000616064 | ENTREZGENE | |
ENST00000616064.2 | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000177721 | GTEx |
HGNC ID | HGNC:33463 | ENTREZGENE |
Human Proteome Map | ANXA2R | Human Proteome Map |
InterPro | ANXA2R | UniProtKB/Swiss-Prot |
KEGG Report | hsa:389289 | UniProtKB/Swiss-Prot |
NCBI Gene | 389289 | ENTREZGENE |
OMIM | 611296 | OMIM |
PANTHER | ANNEXIN-2 RECEPTOR | UniProtKB/Swiss-Prot |
PTHR38820 | UniProtKB/Swiss-Prot | |
Pfam | ANXA2R | UniProtKB/Swiss-Prot |
PharmGKB | PA162380171 | PharmGKB |
UniProt | AX2R_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE |
Q8NHX5 | ENTREZGENE | |
UniProt Secondary | Q8NHX5 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2012-03-13 | ANXA2R | annexin A2 receptor | C5orf39 | chromosome 5 open reading frame 39 | Symbol and/or name change | 5135510 | APPROVED |